The first time the animal gene was successfully modified

Scientists have successfully corrected the animal's genetic code. This groundbreaking study can help find new treatments for current incurable diseases.

For the first time, scientists have successfully treated mice with difficult diluted blood by using a method to repair defective DNA . This finding may help to find new treatments for current incurable diseases such as hemophilia, cystic fibrosis, some genetically blindness, .

Picture 1 of The first time the animal gene was successfully modified
Treating diseases with gene therapy or replacing faulty genes with healthy genes does not cause side effects.(Photo: Corbis) .

According to the Daily Mail , scientists from Philadelphia Children's Hospital (USA) conducted a study on mice suffering from hardy throats. First, they used a special enzyme to separate the faulty genes from the DNA sequence. After that, they inserted healthy genes into the correct gene location.

After 8 months of continuous treatment with the above method, the blood in the mice with severe dilution returned to normal as healthy mice. In particular, this method does not cause side effects.

The idea of ​​treating diseases with gene therapy or replacing faulty genes with healthy genes is not new. But in previous studies, scientists often have trouble inserting healthy genes into the right place. If inserted incorrectly, it can cause cancer.

Dr. Katherine High, the head of the study, said: ' We need to conduct further studies to improve the safety and efficacy of this treatment for densely diluted blood and diseases. similar in people '.

Dyslipidemia mostly occurs in boys, with the incidence of the disease being 1 girl / 5000 boys. Symptoms of the disease include from bruises on the skin to long-term bleeding, which can be life-threatening.

The current method of treating thinning blood thinning disease is by injecting a type of medicine that helps to coagulate several times a week. However, this therapy often causes side effects and costs are too high for most patients with this disease.